|
已读[35]
发布： 2013/07/10 23:05:32
PR Newswire (press release) Suppression of the PGP pump in the gastrointestinal tract allows certain clinically important compounds, (such as paclitaxel and irinotecan , among others) which would normally be effluxed back into the gastrointestinal tract and excreted, to enter the ... and more »
|
|
|
|
|
已读[381]
发布： 2013/07/10 14:35:56
纯是资金推动,我们认为,在新的价格体系和行业格局下,一方面医保控费加剧和竞争性品种价格下降,但另一方面医药市场正在加速向大品种集中(创新+独家),因此行业整体增速...
|
|
|
|
|
已读[44]
发布： 2013/07/09 16:54:33
恒瑞抗肿瘤药伊立替康注射液通过美国FDA认证,成为在美国上市销售的首个中国制造... 一位香港企业家的“中国心” 住建局致歉2岁"杰出人才" 歹徒作案后竟回现场...
|
|
|
|
|
已读[35]
发布： 2013/07/09 16:54:08
Exponent-telegram Do not take REYATAZ (atazanavir sulfate) with the following medicines due to potential for serious side effects:Camptosar® ( irinotecan ), Crixivan® (indinavir), Mevacor®(lovastatin), Zocor® (simvastatin), Uroxatral® (alfuzosin), or Revatio® (sildenafil).
|
|
|
|
|
已读[895]
发布： 2013/07/09 16:54:03
Wall Street Journal *FOLFIRINOX: 5-fluorouracil (5-FU, generics), leucovorin (folinic acid, generics), irinotecan (Pfizer's Camptosar/Campto, Daiichi Sankyo's Topotecin, Yakult Honsha's Campto, generics) and oxaliplatin (Sanofi's Eloxatin/Eloxatine, Yakult Honsha's Elplat ... and more »
|
|
|
|
|
已读[35]
发布： 2013/07/09 16:53:59
pharmabiz.com Although FOLFIRINOX, the drug combination of leucovorin, fluorouracil, irinotecan , and oxaliplatin, has recently been shown to prolong survival in patients with newly-diagnosed advanced disease, many patients could not tolerate this treatment regimen.
|
|
|
|
|
已读[33]
发布： 2013/07/09 16:53:50
MarketWatch (press release) Suppression of the PGP pump in the gastrointestinal tract allows certain clinically important compounds, (such as paclitaxel and irinotecan , among others) which would normally be effluxed back into the gastrointestinal tract and excreted, to enter the ...
|
|
|
|
|
已读[282]
发布： 2013/07/09 16:35:41
The Pharma Letter Two novel therapies, nanoparticle paclitaxel (Celgene [Nasdaq: CELG]/Taiho Pharmaceutical's Abraxane) and rigosertib (Onconova Therapeutics/Baxter International/SymBio Pharmaceuticals' Estybon), both in combination with gemcitabine (Eli Lilly's [NYSE: ...
|
|
|
|
|
已读[47]
发布： 2013/07/06 17:54:18
我们预计①抗肿瘤药:受国家发改委降价影响,预计肿瘤线产品略有增长,其中新品替吉奥有望翻倍,伊立替康逐步替代奥沙利铂,奥沙利铂受基药影响可能略有下滑。②...
|
|
|
|
|
已读[46]
发布： 2013/07/06 17:53:33
一组患者接受5-氟尿嘧啶(5-FU)静脉持续滴注+盆腔超分割放疗,另一组接受5-FU静脉持续滴注+伊立替康+盆腔常规分割放疗。尽管本届大会上直肠癌治疗进展的大型随机...
|
|
|
« 上一页 |
查看结果21-30共248
|
下一页 »
|
|
